Tallness is associated with risk of testicular cancer: evidence for the nutrition hypothesis.

Standard

Tallness is associated with risk of testicular cancer: evidence for the nutrition hypothesis. / Dieckmann, K-P; Hartmann, J T; Classen, J; Lüdde, R; Diederichs, M; Pichlmeier, Uwe.

in: BRIT J CANCER, Jahrgang 99, Nr. 9, 9, 2008, S. 1517-1521.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Dieckmann, K-P, Hartmann, JT, Classen, J, Lüdde, R, Diederichs, M & Pichlmeier, U 2008, 'Tallness is associated with risk of testicular cancer: evidence for the nutrition hypothesis.', BRIT J CANCER, Jg. 99, Nr. 9, 9, S. 1517-1521. <http://www.ncbi.nlm.nih.gov/pubmed/18827809?dopt=Citation>

APA

Dieckmann, K-P., Hartmann, J. T., Classen, J., Lüdde, R., Diederichs, M., & Pichlmeier, U. (2008). Tallness is associated with risk of testicular cancer: evidence for the nutrition hypothesis. BRIT J CANCER, 99(9), 1517-1521. [9]. http://www.ncbi.nlm.nih.gov/pubmed/18827809?dopt=Citation

Vancouver

Dieckmann K-P, Hartmann JT, Classen J, Lüdde R, Diederichs M, Pichlmeier U. Tallness is associated with risk of testicular cancer: evidence for the nutrition hypothesis. BRIT J CANCER. 2008;99(9):1517-1521. 9.

Bibtex

@article{02c0edb8d712486282d3b2cf6f0b863e,
title = "Tallness is associated with risk of testicular cancer: evidence for the nutrition hypothesis.",
abstract = "The pathogenesis of testicular germ cell tumours (GCTs) is potentially influenced by high-energy nutrition during infancy. As adult height is a proxy for childhood nutrition, we investigated the role of nutrition in GCT pathogenesis by comparing stature of patients with healthy men. In a matched case-control study, 6415 patients with GCT were compared with healthy army conscripts (1:6 matching modus) with regard to height (cm) and body mass index (BMI; kg/m(2)). Statistical analysis involved tabulation of descriptive height measures and BMI. Conditional logistic regression models were used to quantify the association of GCT with height, with odds ratios (OR) adjusted for BMI. The literature was searched for studies on stature in GCT patients. Body size is significantly associated with risk of GCT, very tall men (>195 cm) having a GCT risk of OR=3.35 (95% confidence intervals (CI): 2.88-3.90; adjusted). Short stature is protective (OR=0.798; 95% CI: 0.68-0.93). Both histologic subgroups are associated with tallness. Of 16 previous reports, 7 were confirmative, 5 had null and 4 equivocal results. The association of stature with GCT risk accords with the nutrition hypothesis of GCT. This study expands the current view of GCT tumorigenesis by suggesting that high-calorie intake in childhood promotes GCT precursors originating in utero.",
author = "K-P Dieckmann and Hartmann, {J T} and J Classen and R L{\"u}dde and M Diederichs and Uwe Pichlmeier",
year = "2008",
language = "Deutsch",
volume = "99",
pages = "1517--1521",
journal = "BRIT J CANCER",
issn = "0007-0920",
publisher = "NATURE PUBLISHING GROUP",
number = "9",

}

RIS

TY - JOUR

T1 - Tallness is associated with risk of testicular cancer: evidence for the nutrition hypothesis.

AU - Dieckmann, K-P

AU - Hartmann, J T

AU - Classen, J

AU - Lüdde, R

AU - Diederichs, M

AU - Pichlmeier, Uwe

PY - 2008

Y1 - 2008

N2 - The pathogenesis of testicular germ cell tumours (GCTs) is potentially influenced by high-energy nutrition during infancy. As adult height is a proxy for childhood nutrition, we investigated the role of nutrition in GCT pathogenesis by comparing stature of patients with healthy men. In a matched case-control study, 6415 patients with GCT were compared with healthy army conscripts (1:6 matching modus) with regard to height (cm) and body mass index (BMI; kg/m(2)). Statistical analysis involved tabulation of descriptive height measures and BMI. Conditional logistic regression models were used to quantify the association of GCT with height, with odds ratios (OR) adjusted for BMI. The literature was searched for studies on stature in GCT patients. Body size is significantly associated with risk of GCT, very tall men (>195 cm) having a GCT risk of OR=3.35 (95% confidence intervals (CI): 2.88-3.90; adjusted). Short stature is protective (OR=0.798; 95% CI: 0.68-0.93). Both histologic subgroups are associated with tallness. Of 16 previous reports, 7 were confirmative, 5 had null and 4 equivocal results. The association of stature with GCT risk accords with the nutrition hypothesis of GCT. This study expands the current view of GCT tumorigenesis by suggesting that high-calorie intake in childhood promotes GCT precursors originating in utero.

AB - The pathogenesis of testicular germ cell tumours (GCTs) is potentially influenced by high-energy nutrition during infancy. As adult height is a proxy for childhood nutrition, we investigated the role of nutrition in GCT pathogenesis by comparing stature of patients with healthy men. In a matched case-control study, 6415 patients with GCT were compared with healthy army conscripts (1:6 matching modus) with regard to height (cm) and body mass index (BMI; kg/m(2)). Statistical analysis involved tabulation of descriptive height measures and BMI. Conditional logistic regression models were used to quantify the association of GCT with height, with odds ratios (OR) adjusted for BMI. The literature was searched for studies on stature in GCT patients. Body size is significantly associated with risk of GCT, very tall men (>195 cm) having a GCT risk of OR=3.35 (95% confidence intervals (CI): 2.88-3.90; adjusted). Short stature is protective (OR=0.798; 95% CI: 0.68-0.93). Both histologic subgroups are associated with tallness. Of 16 previous reports, 7 were confirmative, 5 had null and 4 equivocal results. The association of stature with GCT risk accords with the nutrition hypothesis of GCT. This study expands the current view of GCT tumorigenesis by suggesting that high-calorie intake in childhood promotes GCT precursors originating in utero.

M3 - SCORING: Zeitschriftenaufsatz

VL - 99

SP - 1517

EP - 1521

JO - BRIT J CANCER

JF - BRIT J CANCER

SN - 0007-0920

IS - 9

M1 - 9

ER -